What KPV Is
KPV is a three-amino-acid fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Research interest in it sits in two places: anti-inflammatory activity, and how it influences immune signalling.
Peptide Therapy
A three-amino-acid fragment of a hormone your body already produces. We use it when inflammation is the thing blocking progress — quiet that down and the injections, the laser and the rehab all start working better.

Why patients choose us
Our Expertise
KPV is a three-amino-acid fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Research interest in it sits in two places: anti-inflammatory activity, and how it influences immune signalling.
It comes up most often for the patient whose inflammation never fully resolves — the joint that stays irritable, the overuse injury that keeps flaring, the rehab programme that stalls every time load increases.
Proposed mechanisms include cytokine activity, immune signalling balance, cell-level inflammatory response, and the pathways behind persistent tissue irritation. Clinical research is still developing and we will say so rather than oversell it.
Dosing is set for you and reviewed by a physician. In practice it is almost always running alongside a rehabilitation programme, not instead of one.
How It Works
A physician reviews your history, medications and goals to determine whether a KPV protocol is appropriate.
You receive dosing, administration and timeline in plain language, sequenced against the rest of your treatment.
Progress is reviewed and the protocol adjusted as your inflammatory picture changes.
Conditions Treated
Patient Guide & Answers
KPV is a three-amino-acid fragment derived from alpha-melanocyte-stimulating hormone. Research interest centres on its anti-inflammatory activity and its effect on immune signalling.
Usually for the patient whose inflammation never fully resolves: the joint that stays irritable, ongoing soft-tissue irritation, or an overuse injury that keeps flaring.
Peptide programs start at $249 per month. Your exact protocol and cost are set at consultation based on your goals.
Yes. Every protocol is prescribed and monitored by our physicians, and compounds are sourced from licensed U.S. 503A/503B pharmacies.
Candidacy depends on your medical history, medications and goals. Some patients are not appropriate for peptide therapy, and our physicians will tell you honestly at consultation.
If inflammatory-related discomfort is holding up your recovery, book a consultation to find out whether a KPV protocol fits your plan.
Important Medical Information
None of the therapies described are FDA-approved to treat, cure or prevent any disease or condition, and they are not a substitute for indicated surgical care. Composition and mechanism characteristics are drawn from published literature and supplier documentation, not from RegenOrtho Palm Beach outcomes. Cellular products are HCT/Ps from accredited U.S. suppliers; per 21 C.F.R. § 1271.3(d) cell factors such as RPA are not classified as HCT/Ps. Donors are U.S.-based, screened and tested by third-party CLIA laboratories. Individual results vary and no outcome is guaranteed. This material is general education, not medical advice. Services are self-pay and are not covered by insurance or Medicare.